Q2 2015
Released Aug 10, 2015, after the close
10-Q filed Aug 10, 2015, 41 days after period end · 0001144204-15-047743
Q2 2015 · 10-Q
Revenue$567.00K$567.00K +28.6% vs Q2 2014+4.2% vs Q1 2015
Net Income-$1.82M-$1.82M N/M vs Q2 2014N/M vs Q1 2015
EPS Diluted-$0.06-$0.06 N/M vs Q2 2014N/M vs Q1 2015
Gross Profit$358,000+19.7%
Operating Income-$594,000N/M
Operating Cash Flowderived-$534,000N/M
Margins · derived
Gross margin63.1%−4.7 pt vs Q2 2014
Operating margin-104.8%+39.5 pt vs Q2 2014
Net margin-320.1%+890.6 pt vs Q2 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $567.00K | $441.00K | $575.00K | $302.00K |
| Net Income | -$1.82M | -$5.34M | -$1.28M | -$754.00K |
| EPS Diluted | -$0.06 | -$0.21 | -$0.10 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR